Safety and efficacy of thymosin α1 and plasma exchange in treatment of patients with chronic severe hepatitis B
Guangjun Liu
Abstract
Guangjun Liu
Abstract
Objective To evaluate the therapeutic effect of thymosin α1 and plasma exchange in patients with chronic severe hepatitis B.Methods Conventional treatments combined with thymosin α1 and plasma exchange in 48 patients with chronic severe hepatitis B were observed.Results After treatment,the symptoms of the patients improved significantly;The TBIL,ALT and HBV DNA were reduced obviously(P0.01,P0.01,P0.01),while ALB and PTA increased(P0.05,P0.01).34(70.8%)survived.Conciusion Thymosin α1 and plasma exchange in treatment of patients with chronic hepatitis B are safe and effective.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the therapeutic effect of thymosin α1 and plasma exchange in patients with chronic severe hepatitis B.Methods Conventional treatments combined with thymosin α1 and plasma exchange in 48 patients with chronic severe hepatitis B were observed.Results After treatment,the symptoms of the patients improved significantly;The TBIL,ALT and HBV DNA were reduced obviously(P0.01,P0.01,P0.01),while ALB and PTA increased(P0.05,P0.01).34(70.8%)survived.Conciusion Thymosin α1 and plasma exchange in treatment of patients with chronic hepatitis B are safe and effective.
Key concepts: Medicine, Thymosin, Chronic hepatitis, Internal medicine, Gastroenterology, Hepatitis B, Hepatitis a virus, Hepatitis